COVID-19

Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?
Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?
Stat
COVID-19
Europe
clinical trials
clinical trial transparency
Flag link:
FDA Looks to Broaden COVID-19 Testing Availability in America
FDA Looks to Broaden COVID-19 Testing Availability in America
Medical Devices and Diagnostics Industry
COVID-19
FDA
diagnostics
Chembio Diagnostics
fraud
Flag link:
A drug from Shkreli's former company Humanigen shows early promise in COVID-19
A drug from Shkreli's former company Humanigen shows early promise in COVID-19
Fierce Biotech
Humanigen
KaloBios
Martin Shkreli
COVID-19
cytokine storm
lenzilumab
Flag link:
PTC Therapeutics taps experimental cancer drug for new COVID-19 trial
PTC Therapeutics taps experimental cancer drug for new COVID-19 trial
Fierce Biotech
PTC Therapeutics
clinical trials
COVID-19
PTC29
Flag link:
Moderna Seals Deal to Supply Israel with Coronavirus Vaccine
Moderna Seals Deal to Supply Israel with Coronavirus Vaccine
Motley Fool
Moderna Therapeutics
vaccines
mRNA-1273
COVID-19
Israel
Flag link:
CureVac gets OK to start testing mRNA COVID-19 vaccine in humans
CureVac gets OK to start testing mRNA COVID-19 vaccine in humans
Fierce Pharma
CureVac
COVID-19
vaccines
MRNA
clinical trials
Flag link:
Cows Help With COVID-19 Treatment, No Bull
Cows Help With COVID-19 Treatment, No Bull
NPR
SAB Biotherapeutics
pandemic
COVID-19
drug development
polyclonal antibodies
Flag link:
AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just one year
AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just one year
Fierce Pharma
AstraZeneca
Pharma CEOs
Pascal Soriot
vaccines
COVID-19
University of Oxford
Flag link:
Researchers: ‘Major Breakthrough’ Drug Reduces Coronavirus Deaths By One-Third
Researchers: ‘Major Breakthrough’ Drug Reduces Coronavirus Deaths By One-Third
Forbes
steroids
dexamethasone
COVID-19
pandemic
clinical trials
Flag link:
Large R&D Investments By Big Pharma Crucial In Fighting Covid-19, But Can It Last?
Large R&D Investments By Big Pharma Crucial In Fighting Covid-19, But Can It Last?
Forbes
R&D
COVID-19
pandemic
drug discovery
drug development
Flag link:
Germany stakes its claim over Curevac
Germany stakes its claim over Curevac
EP Vantage
Germany
CureVac
vaccines
pandemic
COVID-19
Flag link:
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
Motley Fool
FDA
COVID-19
hydroxychloroquine sulfate
hydroxychloroquine
chloroquine phosphate
Emergency Use Authorization
Flag link:
The Red Cross Begins Testing Blood Donations For Covid-19 Antibodies
The Red Cross Begins Testing Blood Donations For Covid-19 Antibodies
Forbes
Red Cross
blood donations
antibodies
COVID-19
Flag link:
How regulators have adapted globally to clinical trials for drugs and biologics during the COVID-19 crisis
How regulators have adapted globally to clinical trials for drugs and biologics during the COVID-19 crisis
RAPS.org
COVID-19
pandemic
clinical trials
regulatory
Flag link:
Novavax Raising $200 Million to Fund Coronavirus and Flu Vaccine Efforts
Novavax Raising $200 Million to Fund Coronavirus and Flu Vaccine Efforts
Motley Fool
Novavax
funding
vaccines
COVID-19
Flu
Flag link:
No Signature Required: FDA Provides Temporary Relief from Obligation to Obtain Physical Signatures for Prescription Drug Samples
No Signature Required: FDA Provides Temporary Relief from Obligation to Obtain Physical Signatures for Prescription Drug Samples
FDA Law Blog
FDA
drug reps
drug samples
sampling
physicians
PDMA
COVID-19
pandemic
Flag link:
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Forbes
Eli Lilly
COVID-19
pandemic
clinical trials
baricitinib
Flag link:
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
Pharmaceutical Business Review
AstraZeneca
vaccines
COVID-19
pandemic
Europe
University of Oxford
Flag link:
How Next-Generation Sequencing Will Help Scientists in the COVID-19 Battle
How Next-Generation Sequencing Will Help Scientists in the COVID-19 Battle
Medical Devices and Diagnostics Industry
Illumina
next generation sequencing
COVID-19
pandemic
Flag link:
EU states back spending up to $2.7 billion upfront on COVID-19 vaccines
EU states back spending up to $2.7 billion upfront on COVID-19 vaccines
Reuters
Europe
COVID-19
vaccines
pandemic
Flag link:

Pages